TMC 649128

Drug Profile

TMC 649128

Alternative Names: HCV-POL (TMC649128) - Medivir/Tibotec/J&J; TMC649128

Latest Information Update: 25 Nov 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medivir AB
  • Class Antivirals
  • Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hepatitis C

Most Recent Events

  • 15 Nov 2011 Discontinued - Phase-I for Hepatitis C in Belgium (PO)
  • 22 Jun 2011 Tibotec completes a phase Ia trial in Healthy volunteers in Belgium (NCT01288677)
  • 22 Jun 2011 Tibotec initiates enrolment in a phase Ib trial for Hepatitis C in Belgium
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top